Aignostics
PrivateLast Round
Series B
Oct 29, 2024
Total Funding Raised
$53.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aignostics is a healthcare technology company that provides an artificial intelligence-driven image analysis platform to enhance precision medicine by providing explainable diagnostic insights for cancer and complex disease diagnosis and treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aignostics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Aignostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 29, 2024 | ||||
| Series A | Sep 15, 2022 | ||||
| Seed | Aug 28, 2020 | ||||
| Accelerator | Jan 1, 2018 |
Aignostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IBB Ventures | Series B, Series A, Seed |
| Athos KG | Series B |
| Ascenion | Series B, Series A |
| Boehringer Ingelheim Venture Fund | Series B, Series A, Seed |
| Wellington Partners | Series B, Series A |
| Future Capital AG | Seed |
| BIH Digital Health Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 13, 2026
Launched a new state-of-the-art pathology foundation model.
- Oct 1, 2025
Pursuing compliance with IEC 62304, EU IVDR, and FDA QSR.
Aignostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aignostics's valuation, stock price, and market status.